China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

Announcement on Obtaining Drug Registration Certificate for Sodium Valproate Oral Solution by Holding Subsidiary Hunan Xiangzhong Pharmaceutical Co., Ltd.

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Sodium Valproate Oral Solution by Holding Subsidiary Hunan Xiangzhong Pharmaceutical Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment